TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · major macro event coming up
LRMR

Larimar Therapeutics Inc

Healthcare · Biotechnology

3.10$ -4.2% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Larimar Therapeutics Inc (LRMR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 165 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LRMR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
104 96 248 237 219 200 170 150 187 146 209 165
98 90 231 231 213 195 165 146 183 142 205 161
39 27 110 32 35 33 21 21 90 85 178 93
96 87 227 226 204 183 158 139 175 137 200 156
– 0.3 1.1 0.8 0.9 1.1 1.1 1.0 1.0 0.7 0.8 0.3
– – – – -0.9 – – – – – – –
11 14 17 26 21 28 26 30 48 68 50 38
6.6 9.5 13 21 16 24 22 27 45 65 48 34
0.7 0.8 0.8 1.0 1.0 1.1 1.1 1.1 1.2 1.1 1.1 1.2
0.8 1.3 1.9 2.9 1.7 2.4 2.3 4.2 11 5.2 8.6 7.6
93 82 231 211 198 172 144 120 139 78 158 127
-176 -189 -203 -225 -240 -269 -298 -325 -372 -435 -464 -497
44 44 54 64 64 64 64 64 78 85 85 104

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?